Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001144204-14-054978

Options or other derivatives

  • VP of Business Development bought 50,000 shares at $0.01 ($500)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Genn John Patrick VP of Business Development 2014-08-27 Purchase · Stock purchase warrant (right to buy) +3,000 $0.01 $30 30,083 D
Genn John Patrick VP of Business Development 2014-08-28 Purchase · Stock purchase warrant (right to buy) +22,000 $0.01 $220 52,083 D
Genn John Patrick VP of Business Development 2014-08-29 Purchase · Stock purchase warrant (right to buy) +15,000 $0.01 $150 67,083 D
Genn John Patrick VP of Business Development 2014-09-08 Purchase · Stock purchase warrant (right to buy) +10,000 $0.01 $100 77,083 D
Loading xslF345X03/v388774_4.xml…